Home/CureLab Oncology/Charles Legg

CL

Charles Legg

COO

CureLab Oncology

Therapeutic Areas

CureLab Oncology Pipeline

Drug	Indication	Phase
Elenagen	Solid Tumors (e.g., Melanoma, Breast, Ovarian, Lung, Renal Cancers)	Phase 2

Leadership Team at CureLab Oncology

Alexander Shneider, Ph.D.

Founder and CEO, BoD Chairman

Vlad Gabai, Ph.D.

Gabriel Levin, MD

Director of Oncology

Ilya Lapshin, JD

General Counsel

View full CureLab Oncology profile